Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants
Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants
Recruiting · NCT06577337 · Registry updated 2026-09-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants | Healthy | Recruiting | Phase 1 | 2026-09-21 | NCT06577337 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinical Pharmacology Unit of Nuvisan GmbH | Neu-Ulm | Germany | 1 |